Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2010-08-17
Original SEC Filing: Click here

---

Webplus: SKBI/20100817/8-K_1/2_EX-99.1/000.htm SEC Original: v194408_ex99-1.htm
Skystar Bio-Pharmaceutical Reports 33% Growth in Revenue From Continuing Operations in Second Quarter Fiscal Year 2010 Gross Margin Remains of 53%; $0.33 Diluted Earnings Per Share; Company reiterates fiscal 2010 guidance of $45.5 Million to $47.5 Million XI’AN, CHINA – August 17, 2010 — – Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) (“Skystar” or the “Company”), Second Quarter 2010 Highlights · Revenue increases

---

---

Webplus: SKBI/20100817/8-K_1/1/000.htm SEC Original: v194408_8k.htm
FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): August 17, 2010 SKYSTAR BIO-PHARMACEUTICAL COMPANY Nevada 001-34394 33-0901534 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Issuer Telephone Number) N/A (Former name or

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2010-08-17CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE